DRG Market Assessment 보고서

Chronic low back pain (CLBP), defined as continuous low back pain lasting for at least three months, represents the largest segment of the chronic pain therapy market. Prescription treatment…

Novartis’s Beovu (brolucizumab-dbll) is the fourth vascular endothelial growth factor (VEGF) inhibitor to launch for the treatment of wet age-related macular degeneration (AMD) in the United…

The moderate to severe atopic dermatitis (AD) market is at the beginning of a revolution with the recent approval of Sanofi/Regeneron’s first-in-class biologic, Dupixent, and a promising suite of…

Diabetic nephropathy, also referred to as diabetic kidney disease, is a common complication of diabetes. The diabetic nephropathy drug market comprises a wide variety of antidiabetic and…

KEY BENEFITS AND USES Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting. Drill down into physicians’ treatment sequences and understand which drugs…

Vitiligo is a chronic skin depigmentation disorder characterized by the destruction of melanocytes. The etiology is multifactorial; both genetic and environmental factors are implicated in disease…

Bronchiectasis is a chronic autoimmune respiratory disorder characterized by recurrent respiratory tract infections including cough and sputum production, resulting in frequent exacerbations and…

Each year in the United States, thousands of patients suffering from end-stage renal disease undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality, these…

Chronic cough could be a result of underlying diseases (e.g., asthma, GERD), a complication of drug therapy (e.g., ACE inhibitors), or have an idiopathic feature without a clear underlying cause…

Attention-deficit / hyperactivity disorder (ADHD) is a common childhood disorder that can persist into adulthood, although diagnosis and treatment initiation can occur at any age. Diagnosis and…

Thechronic obstructive pulmonary disease(COPD) market is continuing its gradual shift away from long-acting beta2 agonist/inhaled corticosteroid fixed-dose combinations(LABA/ICSFDCs) toward LABA/…

Acute heart failure (AHF) is characterized by the rapid onset or aggravation of symptoms of heart failure. The standard of care in AHF has remained largely unchanged since the 1970s, resulting in a…